Melatonin use in managing insomnia in children with autism and other neurogenetic disorders - An assessment by the international pediatric sleep association (IPSA).
Suresh Kotagal,
Beth Malow,
Karen Spruyt,
Guanghai Wang,
Carlos Ernest Bolaños Almeida
et al.
Other
Sleep medicine
2024
24 citazioni
Disegno dello studio
- Tipo di studio
- narrative review / clinical guidance
- Popolazione
- Children with autism spectrum disorder and other neurogenetic disorders with insomnia
- Intervento
- Melatonin use in managing insomnia in children with autism and other neurogenetic disorders - An assessment by the international pediatric sleep association (IPSA). varies
- Comparatore
- placebo or standard care
- Esito primario
- sleep onset, sleep quality in autism/neurogenetic disorder children
- Direzione dell'effetto
- Positive
- Rischio di bias
- Unclear
Abstract
Though it is widely prescribed for improving sleep of children with autism and other neurogenetic disorders, there is a need for practical guidance to clinicians on the use of melatonin for managing insomnia in this population. Because data were either lacking or inconclusive, a task force was established by the International Pediatric Sleep Association (IPSA) to examine the literature based on clinical trials from 2012 onwards. A summary of evidence pertaining to melatonin's utility and potential side effects, practice-related caveats, and insights for use are published herewith.
TL;DR
A summary of evidence pertaining to melatonin's utility and potential side effects, practice-related caveats, and insights for use are published herewith.